M&A

M&A

Diagnostics chain Dr Lal PathLabs to acquire 70% stake in genomics-focused SN Genelab for Rs.168-Cr

BSE Announcement   Economic Times  

Gurugram-based diagnostics chain Dr Lal PathLabs is set to acquire a 70% stake in Gujarat-based SN Genelab for about INR 168 crore. The transaction includes a performance-linked earn-out capped at INR 31.5 crore. SN Genelab will become a subsidiary of the firm.SN Genelab provides diagnostic genomics services. The firm recorded a turnover of INR 57.96 crore in FY26, compared to INR 53.36 crore in FY25 and INR 43.27 crore in FY24.